Term: platinum refractory cancer Pronunciation: (PLA-tih-num reh-FRAK-tor-ee KAN-ser) May 24, 2024October 7, 2025 Description: Cancer that does not respond to treatment with anticancer drugs that contain the metal platinum, such as cisplatin and carboplatin. Related Posts:OPDIVO® (nivolumab) + chemotherapy (fluoropyrimidine…FDA Approves AVASTIN® for Platinum-Sensitive Ovarian CancerFDA Approves Biomarker-Driven ELAHERE® for…Biomarker Driven ELAHERE® in FR alpha-Positive,…LYNPARZA® Superior to Chemotherapy in BRCA Mutated…Durable survival with OPDIVO ® (nivolumab) +…